Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-20

FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Potassium Chloride from Baxter Healthcare Corporation. This action updates the existing NDA for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium chloride (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)